selexipag: Clinical Trials

9 trials of selexipag, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 9

Follow selexipag: new trials by email Literature Review of selexipag trials Research Report on selexipag

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study to Compare Selexipag 400 Microgram Film Coated Tablets Versus Uptravi® (Selexipag) 400 Microgram Film Coated Tablets
Selexipag Film Coated Tablets (T1), Selexipag Film Coated Tablets (T2), Uptravi® (selexipag) film coated tablets - Arterial Hypertension (PAH)
Phase 1CompletedHumanis Saglık Anonim Sirketi302026-04-082026-07-09
Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)
Selexipag Film Coated Tablets, Uptravi® Film Coated Tablets - Pulmonary Arterial Hypertension (PAH)
Phase 1CompletedHumanis Saglık Anonim Sirketi142025-01-092025-04-22
A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects
Selexipag, Clopidogrel - Healthy Subjects
Phase 1CompletedActelion222018-03-052025-06-22
Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects
Midazolam, Selexipag - Healthy Subjects
Phase 1CompletedActelion202016-07-012016-10-13
A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects
Selexipag, Gemfibrozil, Rifampicin - Healthy Subjects
Phase 1CompletedActelion402016-06-012025-02-03
Comparison of Two Dose Strengths of Selexipag in Healthy Adults
Selexipag (adult formulation), Selexipag (pediatric formulation) - Healthy Subjects
Phase 1CompletedActelion202016-06-012025-02-03
Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects
Selexipag for intravenous use, Selexipag for oral use - Healthy Subjects
Phase 1CompletedActelion192015-01-012025-02-03
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
selexipag - Bioequivalence
Phase 1CompletedActelion802012-09-012025-02-03
Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects
selexipag, placebo for selexipag, moxifloxacin - Cardiodynamics, Safety
Phase 1CompletedActelion1592012-06-012014-08-01

Conditions studied

Hypertension (1)  ·  Pulmonary Arterial Hypertension (1)

Sponsors

Actelion (7)  ·  Humanis Saglık Anonim Sirketi (2)

Countries

Belgium (1)  ·  France (1)  ·  India (1)  ·  Jordan (1)  ·  United States (1)

Top investigators

Daniela Baldoni, PhD, PharmD (1)  ·  Margaux Boehler (1)  ·  Matthias Hoch, PhD (1)  ·  Pierre-Eric Juif, PhD (1)  ·  Priska Kaufmann, PhD (1)  ·  Shirin Bruderer (1)  ·  Shirin Bruderer, PhD (1)

Results publications

PMID 27885399, PMID 28639216, PMID 28715853, PMID 32415684

NIH funding

2016 (2)